Search This Blog

Monday, November 4, 2019

Taro Pharmaceutical EPS misses by $0.26, misses on revenue

Taro Pharmaceutical (NYSE:TARO): Q3 GAAP EPS of $1.46 misses by $0.26.
Revenue of $160.85M (+1.2% Y/Y) misses by $7.71M.
Shares +0.08% AH.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)